Articles

Time spent at home among older adults with acute myeloid leukemia receiving azacitidine- or venetoclax-based regimens

University of North Carolina School of Medicine, Chapel Hill, NC, USA; University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC
University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC, USA; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
University of North Carolina School of Medicine, Chapel Hill, NC
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA; University of North Carolina School of Nursing, Chapel Hill, NC
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA; University of North Carolina School of Nursing, Chapel Hill, NC
University of North Carolina School of Medicine, Chapel Hill, NC, USA; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
University of North Carolina School of Medicine, Chapel Hill, NC, USA; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
Haematologica Early view Jul 21, 2022 https://doi.org/10.3324/haematol.2022.280728